News Focus
News Focus
icon url

RobotDroid

07/22/24 11:51 AM

#707550 RE: dennisdave #707542

I do not consider my post to be 'negative', but to be factual criticisms of poor execution. The meeting showed that yes the team has the science down and right, but they also admitted they needed new management, an admission that they have screwed to pooch so far in getting the submissions done, and ignoring the FDA submission altogether. Saying they 'think' they are in fast track designation but not sure is about as stupid a comment as they can make. Ambiguity coupled with silence is their forte.
icon url

Smitty5150

07/22/24 12:16 PM

#707556 RE: dennisdave #707542

Christopher Missling is a good CEO. I am heavily invested in Anavex. He has managed the Compays finances well (minimum dilution) and has a stock pile of cash for runway. He got Anavex added to the Russell. He is also the Company's biggest advocate, as you point out.....He is constantly attending and presenting at investors conferences. As a former WS guy himself, he understands how all this works, unlike Linda Powers and Les Goldman who are constantly squandering oppurtunity.